Private Label Niacinamide Deodorant Manufacturer Low MOQ

Is niacinamide deodorant regulated by the FDA in the United States?

By Blake Mereby · Last reviewed October 5, 2026

In the United States, niacinamide deodorant is regulated by the FDA, but the regulatory classification depends on whether the product makes antiperspirant claims or deodorant-only claims — and that distinction has major compliance implications.

Deodorants that work by masking or reducing odor (without affecting sweat production) are classified as cosmetics under the Federal Food, Drug, and Cosmetic Act. As cosmetics, they are subject to the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which introduced mandatory facility registration, product listing, adverse event reporting, and substantiation requirements effective December 2023 and rolling through 2024. Niacinamide itself is a well-established cosmetic ingredient with a strong safety profile and is not restricted or flagged under current FDA cosmetic regulations.

Antiperspirants — products that claim to reduce sweating — are classified as over-the-counter (OTC) drugs under the FDA's monograph system (21 CFR Part 350). If your niacinamide deodorant also contains aluminum-based active ingredients (aluminum chlorohydrate, aluminum zirconium, etc.) and you make sweat-reduction claims, the product must comply with the OTC antiperspirant monograph, including approved active ingredient concentrations, required label language, and testing protocols. This significantly increases compliance cost and complexity.

For most indie brands, the cleaner regulatory path is to formulate an aluminum-free cosmetic deodorant — using odor-masking, antimicrobial, or skin-conditioning actives — and market niacinamide as a skincare benefit ingredient without drug claims. Avoid language like "stops sweat," "reduces perspiration," or "clinical-strength" unless you are prepared for OTC drug compliance.

MoCRA compliance for a cosmetic deodorant brand requires: registering your facility (or your contract manufacturer's facility) with the FDA, listing each product with its ingredient declaration, maintaining records of adverse event reports, and having safety substantiation on file. These are not optional — FDA enforcement of MoCRA is actively ramping up.

In the EU, cosmetic deodorants are governed by EC Regulation 1223/2009. A Cosmetic Product Safety Report (CPSR) prepared by a qualified safety assessor is mandatory before market placement. Niacinamide is unrestricted in the EU cosmetics regulation. Spray formats may trigger additional requirements under the EU Aerosol Directive.

If you are building for multi-market distribution from the start, partner with a manufacturer experienced in both US MoCRA compliance and EU safety assessment — AJ Cosmo Labs lists manufacturers by regulatory scope so you can filter for this capability before reaching out.

Ingredients in this answer: Niacinamide

Read the full guide on Private Label Niacinamide Deodorant Manufacturer Low MOQ →

More about Private Label Niacinamide Deodorant Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app